Octa says COVID-19 weekly positivity rate in NCR rose from 7% to 10.2% | Inquirer News

Octa says COVID-19 weekly positivity rate in NCR rose from 7% to 10.2%

By: - Reporter / @zacariansINQ
/ 02:02 PM December 05, 2023

MANILA, Philippines — Independent pandemic monitor Octa Research on Tuesday recorded a rise in Metro Manila’s weekly COVID-19 positivity rate, increasing from the previous week’s 7 percent to 10.2 percent.

According to Octa fellow Guido David, the latest figure reflects COVID-19 cases recorded in Metro Manila as of December 3.

“This is accompanied by a 50 percent increase in daily cases over a period of one week,” said David in data he posted through X, formerly Twitter.

ADVERTISEMENT

Despite the rise in cases, David noted that hospital occupancy in the region remained low at 18 percent.

FEATURED STORIES

Based on the Department of Health’s online COVID-19 tracker as of December 4, the total COVID-19 caseload in the country sits at 4,126,765, with recoveries at 4,055,688, active cases at 3,311, and deaths at 66,766.

RELATED STORIES

Marcos tests positive for COVID-19 but will conduct online meetings

Pasig Mayor Vico Sotto gets infected with COVID-19

Cases of COVID-19 from Nov. 28 to Dec. 4 higher than previous week

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, OCTA Research

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.